Autografting Followed by Nonmyeloablative Immunosuppressive Chemotherapy and Allogeneic Peripheral-Blood Hematopoietic Stem-Cell Transplantation as Treatment of Resistant Hodgkin’s Disease and Non-Hodgkin’s LymphomaAngelo Michele Carella, Maria Teresa Corsetti, M. Valbonesi et al.|Journal of Clinical Oncology|2000Cited by 228
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis SurveyNicola Silvestris, Daniele Santini, Francesco Pantano et al.|PLoS ONE|2013Cited by 67
A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantStefano Sacchi, Luciano Masini, Raffaella Marcheselli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2011Cited by 28
Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in <i><scp>KRAS</scp></i> wild‐type metastatic colorectal cancer patients: the ObservEr StudyCarmine Pinto, Francesco Di Costanzo, Francesca Di Fabio et al.|Cancer Medicine|2016Cited by 26
Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr studyGerardo Rosati, Francesco Di Costanzo, Carmine Pinto et al.|Journal of Geriatric Oncology|2018Cited by 13